| Reference |
|---|
Tsuji G, Yumine A, Kawamura K, Takemura M, Kido Nakahara M, Yamamura K, et al. Difamilast, a Topical Phosphodiesterase 4 Inhibitor, Produces Soluble ST2 via the AHR-NRF2 Axis in Human Keratinocytes. Int J Mol Sci. 2024;25: pubmed publisher
|
Cherpaz M, Meugnier E, Seillier G, Pozzi M, Pierrard R, Leboube S, et al. Myocardial transcriptomic analysis of diabetic patients with aortic stenosis: key role for mitochondrial calcium signaling. Cardiovasc Diabetol. 2024;23:239 pubmed publisher
|
Dworok V, H xe4 hnel V, Bannehr M, Paar V, Edlinger C, Lichtenauer M, et al. Soluble Suppression of Tumorigenicity 2 (sST2) in Patients with Predominantly Decompensated Right Heart Failure-A Prospective Observational Study. J Clin Med. 2023;12: pubmed publisher
|
Pan X, Liu J, Li M, Liang Y, Liu Z, Lao M, et al. The association of serum IL-33/ST2 expression with hepatocellular carcinoma. BMC Cancer. 2023;23:704 pubmed publisher
|
Alehagen U, Alexander J, Aaseth J, Larsson A, Svensson E, Opstad T. Effects of an Intervention with Selenium and Coenzyme Q10 on Five Selected Age-Related Biomarkers in Elderly Swedes Low in Selenium: Results That Point to an Anti-Ageing Effect-A Sub-Analysis of a Previous Prospective Double-Blind Placebo-Controlled . Cells. 2023;12: pubmed publisher
|
Wang H, Chen S, Zhong Y, Ge Y, Qiao Z, Li C, et al. Anzhen Risk Evaluation System for Acute Aortic Syndrome (AZSCORE-AAS): protocol for a multicentre prospective cohort study in northern China. BMJ Open. 2023;13:e067469 pubmed publisher
|
Stojkovic S, Kampf S, Harkot O, Nackenhorst M, Brekalo M, Huber K, et al. Soluble ST2 in Patients with Carotid Artery Stenosis-Association with Plaque Morphology and Long-Term Outcome. Int J Mol Sci. 2023;24: pubmed publisher
|
Kletzer J, Hecht S, Ramsauer S, Scharinger B, Kaufmann R, Kammler J, et al. A Story of PA/BSA and Biomarkers to Diagnose Pulmonary Hypertension in Patients with Severe Aortic Valve Stenosis-The Rise of IGF-BP2 and GDF-15. J Cardiovasc Dev Dis. 2023;10: pubmed publisher
|
Teo A, Chia P, Ramireddi G, Khoo S, Yeo T. Clinical and prognostic relevance of sST2 in adults with dengue-associated cardiac impairment and severe dengue. PLoS Negl Trop Dis. 2022;16:e0010864 pubmed publisher
|
Hecht S, Boxhammer E, Kaufmann R, Scharinger B, Reiter C, Kammler J, et al. CT-Diagnosed Sarcopenia and Cardiovascular Biomarkers in Patients Undergoing Transcatheter Aortic Valve Replacement: Is It Possible to Predict Muscle Loss Based on Laboratory Tests?-A Multicentric Retrospective Analysis. J Pers Med. 2022;12: pubmed publisher
|
Topf A, Mirna M, Paar V, Motloch L, Bacher N, Franz M, et al. Differential Diagnosis between Takotsubo Syndrome and Acute Coronary Syndrome-A Prospective Analysis of Novel Cardiovascular Biomarkers for a More Selective Triage. J Clin Med. 2022;11: pubmed publisher
|
Levy S, Kilgallen A, Korse C, Oerlemans M, Sluijter J, Van Laake L, et al. Elevated Serotonin and NT-proBNP Levels Predict and Detect Carcinoid Heart Disease in a Large Validation Study. Cancers (Basel). 2022;14: pubmed publisher
|
Mann O, Kong C, Lucas E, Brosens J, Hanyaloglu A, Brighton P. Expression and function of the luteinizing hormone choriogonadotropin receptor in human endometrial stromal cells. Sci Rep. 2022;12:8624 pubmed publisher
|
Rasheed K, Moens U, Policastro B, Johnsen J, Koljonen V, Sihto H, et al. The Merkel Cell Polyomavirus T-Antigens and IL-33/ST2-IL1RAcP Axis: Possible Role in Merkel Cell Carcinoma. Int J Mol Sci. 2022;23: pubmed publisher
|
Dias I, de Campos Carli S, Vieira E, Mota A, Azevedo P, Anício V, et al. Adiponectin and Stnfr2 peripheral levels are associated with cardiovascular risk in patients with schizophrenia. J Psychiatr Res. 2022;149:331-338 pubmed publisher
|
Griffiths M, Yang J, Vaidya D, Nies M, Brandal S, Ivy D, et al. Biomarkers of Pulmonary Hypertension Are Altered in Children with Down Syndrome and Pulmonary Hypertension. J Pediatr. 2022;241:68-76.e3 pubmed publisher
|
Urban M, Stojkovic S, Demyanets S, Hengstenberg C, Valipour A, Wojta J, et al. Soluble ST2 and All-Cause Mortality in Patients with Chronic Obstructive Pulmonary Disease-A 10-Year Cohort Study. J Clin Med. 2021;11: pubmed publisher
|
Rezar R, Paar V, Seelmaier C, Pretsch I, Schwaiger P, Kopp K, et al. Soluble suppression of tumorigenicity 2 as outcome predictor after cardiopulmonary resuscitation: an observational prospective study. Sci Rep. 2021;11:21756 pubmed publisher
|
Topf A, Mirna M, Bacher N, Paar V, Edlinger C, Motloch L, et al. The Value of Fetuin-A as a Predictor to Identify Takotsubo Patients at Risk of Cardiovascular Events. J Cardiovasc Dev Dis. 2021;8: pubmed publisher
|
Budzianowski J, Hiczkiewicz J, Łojewska K, Kawka E, Rutkowski R, Korybalska K. Predictors of Early-Recurrence Atrial Fibrillation after Catheter Ablation in Women and Men with Abnormal Body Weight. J Clin Med. 2021;10: pubmed publisher
|
Torrente Rodríguez R, Martín C, Gamella M, Pedrero M, Martínez Bosch N, Navarro P, et al. Electrochemical Immunosensing of ST2: A Checkpoint Target in Cancer Diseases. Biosensors (Basel). 2021;11: pubmed publisher
|
Dai H, Penack O, Radujkovic A, Schult D, Majer Lauterbach J, Blau I, et al. Early bilirubinemia after allogeneic stem cell transplantation-an endothelial complication. Bone Marrow Transplant. 2021;56:1573-1583 pubmed publisher
|
Jirak P, Pistulli R, Lichtenauer M, Wernly B, Paar V, Motloch L, et al. Expression of the Novel Cardiac Biomarkers sST2, GDF-15, suPAR, and H-FABP in HFpEF Patients Compared to ICM, DCM, and Controls. J Clin Med. 2020;9: pubmed publisher
|
Demyanets S, Kaun C, Kaider A, Speidl W, Prager M, Oravec S, et al. The pro-inflammatory marker soluble suppression of tumorigenicity-2 (ST2) is reduced especially in diabetic morbidly obese patients undergoing bariatric surgery. Cardiovasc Diabetol. 2020;19:26 pubmed publisher
|
Morello F, Bartalucci A, Bironzo M, Santoro M, Pivetta E, Ianniello A, et al. Prospective diagnostic accuracy study of plasma soluble ST2 for diagnosis of acute aortic syndromes. Sci Rep. 2020;10:3103 pubmed publisher
|
Merz A, Germing U, Kobbe G, Kaivers J, Jauch A, Radujkovic A, et al. EASIX for prediction of survival in lower-risk myelodysplastic syndromes. Blood Cancer J. 2019;9:85 pubmed publisher
|
Radujkovic A, Kordelas L, Krzykalla J, Benner A, Schult D, Majer Lauterbach J, et al. Pre-transplant testosterone and outcome of men after allogeneic stem cell transplantation. Haematologica. 2020;105:1454-1464 pubmed publisher
|
Stojkovic S, Kaider A, Koller L, Brekalo M, Wojta J, Diedrich A, et al. GDF-15 is a better complimentary marker for risk stratification of arrhythmic death in non-ischaemic, dilated cardiomyopathy than soluble ST2. J Cell Mol Med. 2018;22:2422-2429 pubmed publisher
|
Wang Y, Tan X, Gao H, Yuan H, Hu R, Jia L, et al. Magnitude of Soluble ST2 as a Novel Biomarker for Acute Aortic Dissection. Circulation. 2018;137:259-269 pubmed publisher
|
Krychtiuk K, Stojkovic S, Lenz M, Brekalo M, Huber K, Wojta J, et al. Predictive value of low interleukin-33 in critically ill patients. Cytokine. 2018;103:109-113 pubmed publisher
|
Díaz Jiménez D, Núñez L, De la Fuente M, Dubois Camacho K, Sepulveda H, Montecino M, et al. A functional IL1RL1 variant regulates corticosteroid-induced sST2 expression in ulcerative colitis. Sci Rep. 2017;7:10180 pubmed publisher
|
Scott L, Bryant A, Rees A, Down B, Jones R, Thornton C. Production and regulation of interleukin-1 family cytokines at the materno-fetal interface. Cytokine. 2017;99:194-202 pubmed publisher
|
Samuelsson M, Dereke J, Svensson M, Landin Olsson M, Hillman M. Soluble plasma proteins ST2 and CD163 as early biomarkers of nephropathy in Swedish patients with diabetes, 15-34 years of age: a prospective cohort study. Diabetol Metab Syndr. 2017;9:41 pubmed publisher
|
Queiroz G, Costa R, Alcantara Neves N, Nunes de Oliveira Costa G, Barreto M, Carneiro V, et al. IL33 and IL1RL1 variants are associated with asthma and atopy in a Brazilian population. Int J Immunogenet. 2017;44:51-61 pubmed publisher
|
Frampton J, White J, Simon A, Tsuei M, Paczesny S, Takayama S. Aqueous two-phase system patterning of detection antibody solutions for cross-reaction-free multiplex ELISA. Sci Rep. 2014;4:4878 pubmed publisher
|
Miller A, Purves D, McConnachie A, Asquith D, Batty G, Burns H, et al. Soluble ST2 associates with diabetes but not established cardiovascular risk factors: a new inflammatory pathway of relevance to diabetes?. PLoS ONE. 2012;7:e47830 pubmed publisher
|
Sahlander K, Larsson K, Palmberg L. Daily exposure to dust alters innate immunity. PLoS ONE. 2012;7:e31646 pubmed publisher
|
Hong Y, Moon S, Joo Y, Jeon C, Cho M, Ju J, et al. Measurement of interleukin-33 (IL-33) and IL-33 receptors (sST2 and ST2L) in patients with rheumatoid arthritis. J Korean Med Sci. 2011;26:1132-9 pubmed publisher
|
Rechardt M, Shiri R, Matikainen S, Viikari Juntura E, Karppinen J, Alenius H. Soluble IL-1RII and IL-18 are associated with incipient upper extremity soft tissue disorders. Cytokine. 2011;54:149-53 pubmed publisher
|
Mildner M, Storka A, Lichtenauer M, Mlitz V, Ghannadan M, Hoetzenecker K, et al. Primary sources and immunological prerequisites for sST2 secretion in humans. Cardiovasc Res. 2010;87:769-77 pubmed publisher
|
Weir R, Miller A, Murphy G, Clements S, Steedman T, Connell J, et al. Serum soluble ST2: a potential novel mediator in left ventricular and infarct remodeling after acute myocardial infarction. J Am Coll Cardiol. 2010;55:243-50 pubmed publisher
|
Bruneau S, Le Berre L, Hervé C, Valanciute A, Kamal M, Naulet J, et al. Potential role of soluble ST2 protein in idiopathic nephrotic syndrome recurrence following kidney transplantation. Am J Kidney Dis. 2009;54:522-32 pubmed publisher
|
Van T Veer C, van den Pangaart P, van Zoelen M, de Kruif M, Birjmohun R, Stroes E, et al. Induction of IRAK-M is associated with lipopolysaccharide tolerance in a human endotoxemia model. J Immunol. 2007;179:7110-20 pubmed
|